All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2004-005285-20 | Treatment of Acute Migraine when Pain is Mild versus when Pain is Moderate to Severe an Almotriptan Parallel, Placebo Controlled Clinical Trial. Act when mild | 2006-05-09 | due-trials |
| Completed, but no date, and reported results | 2005-000244-90 | A randomized, prospective, cross-over, double blind, placebo-controlled multicentre study to assess the efficacy and tolerability of almotriptan 12.5 mg in the mild pain phase of Mestrual Migraine fol... | bad-data | |
| Completed, but no date, and reported results | 2005-003162-42 | A double-blind, randomized, parallel, multicenter, vehicle-controlled, left/right paired comparison to study the efficacy, safety and tolerability of 1% LAS 37779 cream administered once and twice dai... | bad-data | |
| Reported results | 2005-005101-39 | A 52-WEEK RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO CONTROLLED, MULTICENTRE CLINICAL TRIAL, TO ASSESS THE EFFICACY AND SAFETY OF 200 g OF THE ANTICHOLINERGIC LAS 34273 COMPARED TO PLACEBO, ... | 2008-07-31 | due-trials |
| Reported results | 2005-005804-17 | A Single Dose, Double-Blind, Double-Dummy, 3 Period Cross-Over, Placebo Controlled Clinical Trial To Assess the Rate of Onset of Action of Inhaled LAS 34273 200µg Compared To Placebo and Tiotropium 18... | 2007-08-10 | due-trials |
| Reported results | 2006-000334-12 | A RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND, CROSS-OVER, MONOCENTER STUDY TO EVALUATE THE EFFECT OF A 7-DAY MONTELUKAST TREATMENT ON AIRWAY INFLAMMATION AND FUNCTION BY MEANS OF BRONCHOPROVOCATION ... | 2006-06-14 | due-trials |
| Reported results | 2006-002410-35 | Double-blind, double-dummy, randomized, placebo-controlled, five-armed, multi-centre phase II/III study to evaluate the efficacy and safety of different concentrations of isotretinoin versus doxycycli... | 2008-07-31 | due-trials |
| Reported results | 2006-004874-29 | EVAluation par une echelle visuelle analogique de la satisfaction de patients migraineux apres traitement de 3 crises consécutives par Almogran | 2010-03-04 | due-trials |
| Reported results | 2007-000010-36 | A multiple dose, double-blind, double-dummy, 3 period cross-over, placebo controlled clinical trial to assess the efficacy and safety of once daily inhaled aclidinium bromide 200 µg given either in th... | 2008-03-13 | due-trials |
| Reported results | 2007-000093-23 | Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis | 2008-12-02 | due-trials |
| Reported results | 2007-001793-87 | A Multicenter, Randomized, Double-Blind, Parallel-Group, Vehicle and Active Controlled Trial, to Assess the Efficacy and Safety of LAS37779 Cream for the Treatment of Chronic Plaque Psoriasis | 2008-01-21 | due-trials |
| Reported results | 2007-003392-39 | Standardized sTudy with Almotriptan in eaRly Treatment of migraine, START. An international, open label, single arm, effectiveness and safety study of Almotriptan in primary care | 2009-03-23 | due-trials |
| Reported results | 2007-003415-31 | A PHASE IIa, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO AND ACTIVE COMPARATOR CONTROLLED, 5-WAY CROSSOVER CLINICAL TRIAL TO ASSESS THE ACTIVITY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SING... | 2008-02-19 | due-trials |
| Reported results | 2007-003648-31 | A phase IIa, randomised, multicentre, evaluator-blinded, 4-way crossover clinical trial to study the pharmacokinetics, safety, tolerability and effects on lung function of one day treatment of formote... | 2007-12-12 | due-trials |
| Reported results | 2007-003889-18 | Study on the efficacy of Verrumal(R) compared to placebo and Solaraze(R) in the treatment of actinic keratosis grade I to II | 2009-10-07 | due-trials |
| Reported results | 2007-004435-30 | A RANDOMISED, 4-WEEK, PLACEBO-CONTROLLED, DOUBLE-BLIND, 6 ARM PARALLEL GROUP, DOSE-FINDING CLINICAL TRIAL, TO ASSESS THE EFFICACY, SAFETY AND PHARMACOKINETICS OF THREE DIFFERENT DOSES OF FORMOTEROL (6... | 2008-11-10 | due-trials |
| Reported results | 2008-002141-24 | A phase II, single-center, randomized, controlled, observer-blind study to determine the non-inferiority of a topical mometasone formulation vs a marketed comparator by evaluation of the anti-psoriati... | 2008-07-25 | due-trials |
| Reported results | 2008-003362-26 | A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an"expanded flora t... | 2008-10-10 | due-trials |
| Reported results | 2008-003732-38 | A PHASE IIa, RANDOMISED, DOUBLE-BLIND, MULTIPLE DOSE, PLACEBO CONTROLLED, 3 PERIOD CROSS-OVER, ASCENDING DOSE CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THREE ... | 2008-12-08 | due-trials |
| Reported results | 2008-004756-69 | A randomised, double-blind, placebo-controlled, 4-way crossover clinical trial to assess the efficacy, safety, tolerability and pharmacokinetics of single doses of LAS100977 administered by inhalation... | 2009-02-18 | due-trials |
| Reported results | 2008-006886-10 | A multiple dose, double blind, double-dummy, two-week 3 way cross-over, placebo-controlled clinical trial to assess the efficacy and safety of twice daily inhaled Aclidinium-bromide 400 µg compared to... | 2009-07-01 | due-trials |
| Reported results | 2009-009948-23 | A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an "expanded flora ... | 2009-06-10 | due-trials |
| Reported results | 2009-011600-27 | Efficacia e sicurezza di aclidinio bromuro a due livelli di dose rispetto a placebo per il trattamento di pazienti con broncopneumopatia cronica ostruttiva (BPCO) da moderata a grave | 2010-11-08 | due-trials |
| Reported results | 2009-011931-11 | Explorative, double-blind, randomized, controlled multi-center phase II study to evaluate the efficacy and safety of topically applied combinational product LAS41003 once daily versus corresponding mo... | 2010-06-29 | due-trials |
| Reported results | 2009-012063-33 | Double-blind, randomized, multi-centre phase II study to evaluate the efficacy and safety of topically applied LAS41007 once daily and LAS41007 twice daily versus Solaraze® 3% gel twice daily in the t... | 2010-01-25 | due-trials |
| Reported results | 2009-015901-38 | Efficacy, safety and tolerability of two Fixed-Dose Combinations of Aclidinium bromide with two doses of Formoterol fumarate compared with Aclidinium bromide, Formoterol fumarate and placebo all admin... | 2010-10-22 | due-trials |
| Reported results | 2009-016261-28 | Randomized, observer-blind, multi-center, reference-controlled phase IIb study to evaluate the efficacy of topically applied LAS41002 lotion in the treatment of scalp psoriasis | 2010-04-19 | due-trials |
| Reported results | 2009-016626-14 | A Phase IIa, two-center, randomized, double-blind study with parallel groups to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus corresponding... | 2010-06-16 | due-trials |
| Reported results | 2009-016627-56 | A phase IIa, multi-center, randomized, double-blind study to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus corresponding mono-substances in... | 2011-07-08 | due-trials |
| Reported results | 2009-016629-33 | A 12 day placebo- and reference-controlled, double-blind, single center, randomized, phase II clinical study with an intraindividual comparison, investigating the anti-psoriatic efficacy and the toler... | 2010-03-05 | due-trials |
| Reported results | 2009-017380-42 | Efficacy and safety of three doses of aclidinium bromide compared to placebo and to an active comparator all administered twice daily by inhalation in patients with stable moderate and severe chronic ... | 2010-08-20 | due-trials |
| Reported results | 2009-017407-28 | A phase II, single-center, randomized, controlled, double-blind study to assess effects on skin conditions and patient reported outcome of a topical formulation containing LAS41002 on lesional skin in... | 2010-03-29 | due-trials |
| Reported results | 2010-018355-10 | An Investigator-blind, Controlled Study to Assess the Efficacy of Five Distinct Combinations of LAS 41004 in Different Concentrations Compared to Placebo and to Two Active Controls in a Psoriasis-Plaq... | 2010-09-06 | due-trials |
| Reported results Terminated | 2010-022244-20 | Double-blind, randomized, vehicle- and comparator-controlled, multicenter trial to evaluate the efficacy and safety of LAS41007 in the treatment of actinic keratosis | 2012-07-16 | due-trials |
| Reported results | 2010-022281-27 | An Investigator-blind, Controlled Study to Assess the Efficacy and Safety of different formulations of LAS 41004 Compared to Placebo and to Active Control in a Psoriasis-Plaque-Test | 2011-02-28 | due-trials |
| Reported results | 2010-022980-37 | A prospective comparator controlled randomized exploratory study on the efficacy of LAS 41005 compared to cryotherapy in subjects with hyperkeratotic actinic keratosis | 2012-08-20 | due-trials |
| Reported results | 2011-000186-13 | An Investigator-blind, Controlled Exploratory Study to Assess the Efficacy and Safety of Different Concentrations of Active Ingredients in the project Formulations of LAS 41004 Compared to a Bland Oin... | 2011-07-11 | due-trials |
| Reported results | 2011-000428-14 | A PHASE IIA, RANDOMISED, SINGLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, 6 WAY COMPLETE CROSS-OVER, PLACEBO CONTROLLED CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF 4 DOSES OF LAS100977 Q... | 2012-01-23 | due-trials |
| Reported results | 2011-000429-58 | A PHASE IIA, RANDOMISED, SINGLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, 6 WAY COMPLETE CROSS-OVER, PLACEBO CONTROLLED CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF 4 STRENGTHS OF LAS1009... | 2011-12-27 | due-trials |
| Reported results | 2011-000834-12 | A MULTIPLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED, PARALLEL CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY INHALED ACLIDINIUM BROMIDE 400 μg COMPARED TO PLACEBO AND TO T... | 2012-03-15 | due-trials |
| Reported results | 2011-001384-45 | A 22 day bland ointment and reference-controlled, investigator-blind, single center, randomized, proof of concept clinical study with an intraindividual comparison investigating the anti-psoriatic eff... | 2011-08-12 | due-trials |
| Reported results | 2011-001524-38 | EFFICACY AND SAFETY OF ACLIDINIUM BROMIDE/FORMOTEROL FUMARATE FIXED-DOSE COMBINATIONS COMPARED WITH INDIVIDUAL COMPONENTS AND PLACEBO WHEN ADMINISTERED TO PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULM... | 2013-01-04 | due-trials |
| Completed, but no date, and reported results | 2011-002258-30 | NEUROPHYSIOLOGIC STUDY AIMED AT EVALUATING ON EFFECT OF SATIVEX® ON SPASTICITY IN PROGRESSIVE MULTIPLE SCLEROSIS studio neurofisiologico per valutare l'effetto del sativex sulla spasticita' in scl... | bad-data | |
| Reported results | 2011-002665-38 | A MULTIPLE DOSE, RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, 2 PERIOD CROSSOVER CLINICAL TRIAL TO ASSESS THE EFFECT OF ACLIDINIUM BROMIDE 400 MCG BID ON EXERCISE ENDURANCE IN PATIENTS WITH STABLE MO... | 2012-06-04 | due-trials |
| Reported results | 2012-000055-13 | A multi-center, randomized, double-blind, three-arm, 16 week, adaptive phase III clinical study to investigate the efficacy and safety of LAS41008 vs LASW1835 and vs Placebo in patients with moderate... | 2015-10-03 | due-trials |
| Reported results | 2013-000116-14 | A RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF TWICE-DAILY ACLIDINIUM BROMIDE /FORMOTEROL FUMARATE COMPARED WITH TWICE-DAILY SALM... | 2014-08-04 | due-trials |
| Ongoing | 2013-001248-67 | CLINICAL TRIAL PHASE IIIb to evaluate predictors of response to linaclotide in patients with irritable bowel syndrome and explore the impact on intestinal symptoms ENSAYO CLÍNICO FASE IIIb para eva... | not-yet-due | |
| Reported results | 2013-003373-10 | A DOUBLE-BLIND, PLACEBO-CONTROLLED, 2 PERIOD CROSSOVER CLINICAL STUDY TO ASSESS THE EFFECT OF ACLIDINIUM BROMIDE 400 ΜCG BID ON COPD SYMPTOMS AND SLEEP QUALITY AFTER 3 WEEKS OF TREATMENT IN PATIENTS W... | 2015-06-03 | due-trials |
| Reported results | 2013-003757-22 | A phase IIa, 28-day treatment, multi-center, randomized, comparator-controlled, observer-blind trial with intra-individual left/right comparison to investigate the anti-psoriatic efficacy and the safe... | 2014-10-13 | due-trials |
| Reported results | 2013-004519-28 | A phase II trial to evaluate the anti-psoriatic efficacy and tolerability of tazarotene in a gel formulation in patients with mild to moderate nail psoriasis - parallel group comparison | 2015-05-07 | due-trials |
| Reported results | 2014-001171-31 | Multicentre, randomized, parallel, double-blind, vehicle controlled study to evaluate the efficacy and safety of Actikerall® solution in the field-directed treatment of actinic keratoses grade I to II... | 2015-08-10 | due-trials |
| Reported results | 2015-004451-40 | SATIVEX® AS ADD-ON THERAPY VS. FURTHER OPTIMIZED FIRST-LINE ANTISPASTICS THE S A V A N T TRIAL | 2017-05-23 | due-trials |
| Reported results | 2017-001368-40 | Open clinical study to assess long-term efficacy and safety of dimethyl fumarate in adults with moderate to severe chronic plaque psoriasis in real practice (DIMESKIN 1 Trial) Estudio clínico abie... | 2020-04-02 | due-trials |
| Completed, but no date, and reported results | 2017-003818-11 | An open-label clinical study to evaluate the long-term efficacy and tolerability of treatment with dimethyl fumarate (DMF) in adults with chronic plaque psoriasis (Study DIMESKIN 2). Studio clinico... | bad-data | |
| Listed as ongoing, but also has a completion date and reported results | 2018-004010-18 | An Open Label, Multi-Center, 24 Week, Exploratory Study to Assess the Efficacy and Safety of Skilarence® (Dimethyl Fumarate) in Patients with Moderate Plaque Psoriasis | 2021-06-24 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2019-000817-35 | An open-label, randomized, Phase IV study, to assess the efficacy and safety of tildrakizumab in patients with moderate to severe chronic plaque psoriasis who are non-responders to dimethyl fumarate t... | 2022-02-16 | bad-data |
| Reported results | 2019-000818-11 | Clinical study to evaluate the efficacy and safety of a combination therapy with dimethyl fumarate (DMF) and NB-UVB phototherapy (versus DMF monotherapy) in adults with moderate-to-severe chronic plaq... | 2021-07-02 | due-trials |
| Ongoing, reported early | 2019-002804-42 | An international, multicentre, open label, interventional phase IV clinical study to investigate the efficacy and safety of tildrakizumab 100 mg in patients with moderate-to-severe chronic plaque psor... | not-yet-due | |
| Reported results Terminated | 2019-003218-15 | A phase IV interventional study to assess the disease-modifying effect of long-term treatment with tildrakizumab in adult patients with moderate-to-severe plaque psoriasis | 2020-07-31 | due-trials |
| Listed as ongoing, but also has a completion date | 2021-002967-23 | A Randomised, Double-Blind, Placebo-Controlled Phase 3 Clinical Trial to Assess the Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adult and Adolescent Patients Wit... | 2024-04-30 | bad-data |
| Other | 2021-004349-18 | A Phase 4, Multi-centre, Randomized, Evaluator-blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Evaluate the Long-term Safety of Tirbanibulin 10 mg/g Ointment... | not-yet-due | |
| Listed as ongoing, but also has a completion date | 2022-001251-16 | Open phase IV study to assess the impact of tirbanibulin on the well-being of patients with actinic keratoses (TIRBASKIN). Estudio abierto de fase IV para evaluar el impacto de tirbanibulina en el ... | 2023-11-22 | bad-data |